OSTEOSCREEN PANEL Test – A Comprehensive Assessment of Bone Health
At DNA Labs UAE, we offer the OSTEOSCREEN PANEL test, a diagnostic tool designed to assess bone health and screen for osteoporosis. This test measures levels of specific bone turnover markers in the blood, providing valuable information about the rate at which bone is being broken down and rebuilt.
Test Components
- Calcium
- Phosphorus
- PTH-Intact
- Vitamin D, 25-Hydroxy
Test Price
The OSTEOSCREEN PANEL test is priced at 820.0 AED.
Sample Condition
A minimum of 4 mL serum from 1 SST is required for the test. It is recommended to collect the sample between 8-10 am in a fasting condition. The serum should be separated and frozen within 30 minutes. The sample must be shipped frozen and should not be thawed.
Report Delivery
The test reports are delivered daily.
Method
The OSTEOSCREEN PANEL test is performed using the CLIA (Clinical Laboratory Improvement Amendments) method and Spectrophotometry.
Test Type
The test is specifically designed to diagnose disorders of the bone.
Referring Doctor
An endocrinologist is the appropriate doctor to consult for the OSTEOSCREEN PANEL test.
Pre Test Information
It is recommended to collect the sample between 8-10 am, preferably in a fasting condition.
Test Details
The OSTEOSCREEN PANEL test is a non-invasive diagnostic tool that involves a simple blood draw from the arm. The blood sample is then analyzed in a laboratory to measure the levels of specific bone turnover markers, such as serum C-terminal telopeptide (CTX) and serum procollagen type 1 N-terminal propeptide (P1NP).
These markers reflect the activity of osteoclasts and osteoblasts, the cells responsible for bone resorption and formation, respectively. Based on the results of the OSTEOSCREEN PANEL test, healthcare providers can assess a patient’s bone health and determine their risk of osteoporosis.
Elevated levels of bone turnover markers may indicate increased bone resorption, suggesting a higher risk of osteoporosis. Conversely, lower levels may indicate decreased bone formation, which can also be a concern.
The OSTEOSCREEN PANEL test is often used in conjunction with other diagnostic tools, such as dual-energy X-ray absorptiometry (DXA) scans, to provide a more comprehensive evaluation of bone health. It helps guide treatment decisions, such as the need for lifestyle modifications, dietary changes, or medication to improve bone density and reduce the risk of fractures.
It’s important to note that the OSTEOSCREEN PANEL test is not a standalone diagnostic tool for osteoporosis. It should be interpreted by a healthcare professional in conjunction with other clinical information as part of a comprehensive evaluation.
Overall, the OSTEOSCREEN PANEL test provided by DNA Labs UAE is a valuable tool for assessing bone health and identifying individuals at risk for osteoporosis. Early detection and intervention based on the test results can help prevent fractures and improve overall bone health.
| Test Name | OSTEOSCREEN PANEL Test |
|---|---|
| Components | *Calcium*Phosphorus*PTH-Intact*Vitamin D, 25-Hydroxy |
| Price | 820.0 AED |
| Sample Condition | 4 mL (2 mL min.) serum from 1 SST. Collect sample between 8-10 am in a fasting condition,separate serum and freeze within 30 minutes. Ship frozen. DO NOT THAW. |
| Report Delivery | Daily |
| Method | CLIA, Spectrophotometry |
| Test type | Disorders of Bone |
| Doctor | Endocrinologist |
| Test Department: | |
| Pre Test Information | Collect preferably fasting sample between 8??10 am. |
| Test Details |
The OSTEOSCREEN PANEL test is a diagnostic tool used to assess bone health and screen for osteoporosis. It measures levels of specific bone turnover markers in the blood, which can indicate the rate at which bone is being broken down and rebuilt. The test involves a simple blood draw, usually from the arm. The blood sample is then analyzed in a laboratory to measure the levels of bone turnover markers such as serum C-terminal telopeptide (CTX) and serum procollagen type 1 N-terminal propeptide (P1NP). These markers reflect the activity of osteoclasts and osteoblasts, the cells responsible for bone resorption and formation, respectively. Based on the results of the OSTEOSCREEN PANEL test, healthcare providers can assess a patient’s bone health and determine their risk of osteoporosis. Elevated levels of bone turnover markers may indicate increased bone resorption, suggesting a higher risk of osteoporosis. Conversely, lower levels may indicate decreased bone formation, which can also be a concern. The test is often used in conjunction with other diagnostic tools, such as dual-energy X-ray absorptiometry (DXA) scans, to provide a more comprehensive evaluation of bone health. It can help guide treatment decisions, such as the need for lifestyle modifications, dietary changes, or medication to improve bone density and reduce the risk of fractures. It’s important to note that the OSTEOSCREEN PANEL test is not a standalone diagnostic tool for osteoporosis. It is used as part of a comprehensive evaluation and should be interpreted by a healthcare professional in conjunction with other clinical information. Overall, the OSTEOSCREEN PANEL test provides valuable information about bone health and can help identify individuals at risk for osteoporosis. Early detection and intervention can help prevent fractures and improve overall bone health. |
